Royal Bank Of Canada Forecasts Strong Price Appreciation for Privia Health Group (NASDAQ:PRVA) Stock

Privia Health Group logo with Healthcare background
Image from MarketBeat Media, LLC.

Key Points

  • Royal Bank of Canada raised its price target for Privia Health Group from $31 to $32 and maintained an “outperform” rating, implying 32.73% upside from the stock’s current price.
  • Analyst sentiment is broadly positive: seven analysts rate PRVA a Buy and three a Hold, with a consensus “Moderate Buy” rating and an average target price of $31.30.
  • Privia beat quarterly estimates, reporting EPS of $0.21 versus $0.09 expected and revenue of $656.96 million versus $610.72 million; revenue rose 13.2% year over year.
  • Five stocks we like better than Privia Health Group.

Privia Health Group (NASDAQ:PRVA - Get Free Report) had its price objective lifted by equities research analysts at Royal Bank Of Canada from $31.00 to $32.00 in a report released on Thursday, Benzinga reports. The firm presently has an "outperform" rating on the stock. Royal Bank Of Canada's price objective points to a potential upside of 32.73% from the stock's current price.

Several other research firms also recently issued reports on PRVA. Citigroup reaffirmed a "buy" rating on shares of Privia Health Group in a research note on Thursday, July 23rd. Canaccord Genuity Group lifted their target price on shares of Privia Health Group from $32.00 to $33.00 and gave the stock a "buy" rating in a research report on Friday, November 6th. Zacks Research raised shares of Privia Health Group from a "strong sell" rating to a "hold" rating in a report on Wednesday, August 5th. Weiss Ratings restated a "hold (c)" rating on shares of Privia Health Group in a research report on Tuesday, September 29th. Finally, Piper Sandler raised their price target on shares of Privia Health Group from $36.00 to $38.00 and gave the company an "overweight" rating in a research note on Friday, November 6th. Seven analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. According to data from MarketBeat.com, Privia Health Group currently has an average rating of "Moderate Buy" and an average target price of $31.30.

Check Out Our Latest Research Report on PRVA

Privia Health Group Trading Down 2.0%

Privia Health Group stock traded down $0.49 during mid-day trading on Thursday, reaching $24.11. The company had a trading volume of 107,901 shares, compared to its average volume of 1,080,877. The business has a fifty day simple moving average of $21.66 and a 200 day simple moving average of $22.68. The company has a market cap of $3.08 billion, a P/E ratio of 93.28 and a beta of 0.76. Privia Health Group has a fifty-two week low of $18.92 and a fifty-two week high of $28.82.

Privia Health Group (NASDAQ:PRVA - Get Free Report) last released its quarterly earnings data on Thursday, November 5th. The company reported $0.21 earnings per share for the quarter, beating the consensus estimate of $0.09 by $0.12. Privia Health Group had a return on equity of 4.20% and a net margin of 1.43%. The company had revenue of $656.96 million for the quarter, compared to the consensus estimate of $610.72 million. During the same quarter last year, the business posted $0.29 EPS. Privia Health Group's revenue for the quarter was up 13.2% on a year-over-year basis. Research analysts forecast that Privia Health Group will post 0.28 EPS for the current year.

Institutional Trading of Privia Health Group

A number of institutional investors and hedge funds have recently added to or reduced their stakes in PRVA. Public Employees Retirement System of Ohio bought a new stake in shares of Privia Health Group in the 2nd quarter valued at $26,000. Heritage Family Offices LLP acquired a new position in Privia Health Group in the third quarter valued at $34,000. Parallel Advisors LLC lifted its holdings in Privia Health Group by 313.7% in the third quarter. Parallel Advisors LLC now owns 2,180 shares of the company's stock valued at $43,000 after buying an additional 1,653 shares during the period. Allworth Financial LP acquired a new position in Privia Health Group in the second quarter valued at $48,000. Finally, Nykredit A S bought a new stake in Privia Health Group during the second quarter valued at $50,000. Institutional investors and hedge funds own 94.48% of the company's stock.

Privia Health Group Company Profile

(Get Free Report)

Privia Health Group, Inc. is a physician enablement company that partners with independent medical groups, health systems and other providers. Its technology-enabled platform is designed to help physicians manage their practices and deliver coordinated care, while retaining their clinical independence. The company provides practice management, technology, care coordination and population health services. It also helps providers participate in value-based care arrangements, which tie payments more closely to the quality and efficiency of care.

See Also

Analyst Recommendations for Privia Health Group (NASDAQ:PRVA)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Privia Health Group Right Now?

Before you consider Privia Health Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Privia Health Group wasn't on the list.

While Privia Health Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 7 Best High-Yield Dividend Stocks for 2027 Cover

Looking for higher dividend income in 2027? Discover seven high-yield dividend stocks with attractive payouts, proven dividend histories and growth potential.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines